Cargando…
Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
Neoadjuvant chemo(radio)therapy followed by surgery is the standard of care for patients with locally advanced resectable esophageal adenocarcinoma (EAC). There is increasing evidence that drug resistance might be related to genomic heterogeneity. We investigated whether genomic tumor heterogeneity...
Autores principales: | Obulkasim, Askar, Ylstra, Bauke, van Essen, Hendrik F., Benner, Christian, Stenning, Sally, Langley, Ruth, Allum, William, Cunningham, David, Inam, Imran, Hewitt, Lindsay C., West, Nicolas P., Meijer, Gerrit A., van de Wiel, Mark A., Grabsch, Heike I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190081/ https://www.ncbi.nlm.nih.gov/pubmed/27286451 http://dx.doi.org/10.18632/oncotarget.9857 |
Ejemplares similares
-
Stepwise classification of cancer samples using clinical and molecular data
por: Obulkasim, Askar, et al.
Publicado: (2011) -
Semi-supervised adaptive-height snipping of the hierarchical clustering tree
por: Obulkasim, Askar, et al.
Publicado: (2015) -
FocalCall: An R Package for the Annotation of Focal Copy Number Aberrations
por: Krijgsman, Oscar, et al.
Publicado: (2014) -
Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism
por: Carvalho, Beatriz, et al.
Publicado: (2012) -
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial
por: Davarzani, Nasser, et al.
Publicado: (2018)